Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients

Abstract To date, only few data concerning the biologically active, free form of testosterone (FT) are available in metastatic prostate cancer (mPC) and the impact of FT on disease, therapy and outcome is largely unknown. We retrospectively studied the effect of docetaxel on FT and total testosteron...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paula Kappler, Michael A. Morgan, Philipp Ivanyi, Stefan J. Brunotte, Arnold Ganser, Christoph W. M. Reuter
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/a789714755e147bb96b1cf2cae3cdbfa
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!